NON-SEGMENTAL VITILIGO
Clinical trials for NON-SEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for vitiligo: experimental drug aims to restore skin color
Disease control Recruiting nowThis study tests an experimental drug called GIA632 in 210 adults with non-segmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the drug can safely reduce the size of these patches, especially on the face, and to find the best dose for futu…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:53 UTC
-
New pill aims to restore skin color in vitiligo patients
Disease control Recruiting nowThis study tests an experimental tablet called VC005 for people with non-segmental vitiligo, a condition that causes white patches on the skin. About 120 adults aged 18 to 70 will take the tablet or a placebo for 24 weeks to see if it helps bring back color to the face. The goal …
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Poking for pigment: can needling beat microneedling for vitiligo?
Disease control Recruiting nowThis study tests whether needling or microneedling, followed by narrowband UVB light, works better to bring back skin color in people with stable non-segmental vitiligo. Eighty adults aged 15–60 with vitiligo for over a year will receive one of the two treatments. The main goal i…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE4 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated May 11, 2026 20:40 UTC